You are here

  • Home
  • Archive
  • Volume 31, Issue Suppl 3
  • 229 Avelumab combined with pegylated liposomal doxorubicin in platinum-resistant/refractory ovarian cancer: biomarker analyses from JAVELIN Ovarian 200

Article metrics

Article menu

Download PDFPDF

Ovarian cancer
229 Avelumab combined with pegylated liposomal doxorubicin in platinum-resistant/refractory ovarian cancer: biomarker analyses from JAVELIN Ovarian 200
Free

 

Online download statistics by month:

Online download statistics by month: October 2021 to March 2023

AbstractFullPdf
Oct 202161012
Nov 202171014
Dec 20211104
Jan 202211808
Feb 20221702
Mar 20221603
Apr 20221204
May 202218011
Jun 20221606
Jul 20222503
Aug 20221606
Sep 202228013
Oct 20221704
Nov 20221502
Dec 20224407
Jan 20232606
Feb 20233103
Mar 20232800
Total5700108